-
1
-
-
64349105221
-
Lipid management in the prevention of stroke: Review and updated meta-analysis of statins for stroke prevention
-
Amarenco P., and, Labreuche J., (2009) Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 8, 453-463.
-
(2009)
Lancet Neurol.
, vol.8
, pp. 453-463
-
-
Amarenco, P.1
Labreuche, J.2
-
2
-
-
84862929090
-
Systematic review and meta-analysis of the efficacy of statins in experimental stroke
-
Baryan H. K., Allan S. M., Vail A., and, Smith C. J., (2012) Systematic review and meta-analysis of the efficacy of statins in experimental stroke. Int. J. Stroke 7, 150-156.
-
(2012)
Int. J. Stroke
, vol.7
, pp. 150-156
-
-
Baryan, H.K.1
Allan, S.M.2
Vail, A.3
Smith, C.J.4
-
3
-
-
2942705774
-
Safety of statins: Focus on clinical pharmacokinetics and drug interactions
-
Bellosta S., Paoletti R., and, Corsini A., (2004) Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation 109, III50-57. (Pubitemid 38786444)
-
(2004)
Circulation
, vol.109
, Issue.SUPPL.
-
-
Bellosta, S.1
Paoletti, R.2
Corsini, A.3
-
4
-
-
45449084852
-
Neuroprotection by pravastatin in acute ischemic stroke in rats
-
DOI 10.1016/j.brainresrev.2007.10.010, PII S0165017307002305
-
Berger C., Xia F., Maurer M. H., and, Schwab S., (2008) Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Res. Rev. 58, 48-56. (Pubitemid 351852927)
-
(2008)
Brain Research Reviews
, vol.58
, Issue.1
, pp. 48-56
-
-
Berger, C.1
Xia, F.2
Maurer, M.H.3
Schwab, S.4
-
5
-
-
79955465542
-
Statin treatment and functional outcome after ischemic stroke: Case-control and meta-analysis
-
Biffi A., Devan W. J., Anderson C. D., Cortellini L., Furie K. L., Rosand J., and, Rost N. S., (2011) Statin treatment and functional outcome after ischemic stroke: case-control and meta-analysis. Stroke 42, 1314-1319.
-
(2011)
Stroke
, vol.42
, pp. 1314-1319
-
-
Biffi, A.1
Devan, W.J.2
Anderson, C.D.3
Cortellini, L.4
Furie, K.L.5
Rosand, J.6
Rost, N.S.7
-
6
-
-
73349104623
-
NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models
-
Cui W., Matsuno K., Iwata K., et al., (2009) NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models. J. Pharmacol. Sci. 111, 260-268.
-
(2009)
J. Pharmacol. Sci.
, vol.111
, pp. 260-268
-
-
Cui, W.1
Matsuno, K.2
Iwata, K.3
-
7
-
-
1242339543
-
The Search for Neuroprotective Strategies in Stroke
-
Danton G. H., and, Dietrich W. D., (2004) The search for neuroprotective strategies in stroke. AJNR Am. J. Neuroradiol. 25, 181-194. (Pubitemid 38235294)
-
(2004)
American Journal of Neuroradiology
, vol.25
, Issue.2
, pp. 181-194
-
-
Danton, G.H.1
Dietrich, W.D.2
-
8
-
-
0017043554
-
Competitive inhibition of 3 hydroxy 3 methylglutaryl coenzyme A reductase by ML 236A and ML 236B fungal metabolites, having hypocholesterolemic activity
-
DOI 10.1016/0014-5793(76)80996-9
-
Endo A., Kuroda M., and, Tanzawa K., (1976) Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett. 72, 323-326. (Pubitemid 8017240)
-
(1976)
FEBS Letters
, vol.72
, Issue.2
, pp. 323-326
-
-
Endo, A.1
Kuroda, M.2
Tanzawa, K.3
-
9
-
-
7644242146
-
Effects of statins on endothelium and signaling mechanisms
-
DOI 10.1161/01.STR.0000143319.73503.38
-
Endres M., and, Laufs U., (2004) Effects of statins on endothelium and signaling mechanisms. Stroke 35, 2708-2711. (Pubitemid 39458376)
-
(2004)
Stroke
, vol.35
, Issue.SUPPL. 1
, pp. 2708-2711
-
-
Endres, M.1
Laufs, U.2
-
10
-
-
0032555154
-
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
-
DOI 10.1073/pnas.95.15.8880
-
Endres M., Laufs U., Huang Z., Nakamura T., Huang P., Moskowitz M. A., and, Liao J. K., (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA 95, 8880-8885. (Pubitemid 28350583)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.15
, pp. 8880-8885
-
-
Endres, M.1
Laufs, U.2
Huang, Z.3
Nakamura, T.4
Huang, P.5
Moskowitz, M.A.6
Liao, J.K.7
-
11
-
-
79952497376
-
Treatment of intracerebral hemorrhage in animal models: Meta-analysis
-
Frantzias J., Sena E. S., Macleod M. R., and, Al-Shahi Salman R., (2011) Treatment of intracerebral hemorrhage in animal models: meta-analysis. Ann. Neurol. 69, 389-399.
-
(2011)
Ann. Neurol.
, vol.69
, pp. 389-399
-
-
Frantzias, J.1
Sena, E.S.2
MacLeod, M.R.3
Al-Shahi Salman, R.4
-
12
-
-
0036890520
-
Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering
-
DOI 10.1016/S0002-9149(02)02841-2, PII S0002914902028412
-
George S. J., Dhond A. J., Alderson S. M., and, Ezekowitz M. D., (2002) Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering. Am. J. Cardiol. 90, 1237-1239. (Pubitemid 35346882)
-
(2002)
American Journal of Cardiology
, vol.90
, Issue.11
, pp. 1237-1239
-
-
George, S.J.1
Dhond, A.J.2
Alderson, S.M.3
Ezekowitz, M.D.4
-
13
-
-
0023876839
-
HMG-CoA reductase inhibitors for treatment of hypercholesterolemia
-
Grundy S. M., (1988) HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl. J. Med. 319, 24-33.
-
(1988)
N Engl. J. Med.
, vol.319
, pp. 24-33
-
-
Grundy, S.M.1
-
14
-
-
20144380435
-
HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons
-
DOI 10.1016/j.brainres.2004.12.051
-
Hayashi T., Hamakawa K., Nagotani S., et al., (2005) HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons. Brain Res. 1037, 52-58. (Pubitemid 40362381)
-
(2005)
Brain Research
, vol.1037
, Issue.1-2
, pp. 52-58
-
-
Hayashi, T.1
Hamakawa, K.2
Nagotani, S.3
Jin, G.4
Li, F.5
Deguchi, K.6
Sehara, Y.7
Zhang, H.8
Nagano, I.9
Shoji, M.10
Abe, K.11
-
15
-
-
33751182650
-
Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke
-
Hong H., Zeng J. S., Kreulen D. L., Kaufman D. I., and, Chen A. F., (2006) Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke. Am. J. Physiol. Heart Circ. Physiol. 291, H2210-2215.
-
(2006)
Am. J. Physiol. Heart Circ. Physiol.
, vol.291
-
-
Hong, H.1
Zeng, J.S.2
Kreulen, D.L.3
Kaufman, D.I.4
Chen, A.F.5
-
16
-
-
79960141471
-
The immunology of stroke: From mechanisms to translation
-
Iadecola C., and, Anrather J., (2011) The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796-808.
-
(2011)
Nat. Med.
, vol.17
, pp. 796-808
-
-
Iadecola, C.1
Anrather, J.2
-
17
-
-
78651107869
-
Synergistic benefit of combined amlodipine plus atorvastatin on neuronal damage after stroke in Zucker metabolic rat
-
Kawai H., Deguchi S., Deguchi K., et al., (2011) Synergistic benefit of combined amlodipine plus atorvastatin on neuronal damage after stroke in Zucker metabolic rat. Brain Res. 1368, 317-323.
-
(2011)
Brain Res.
, vol.1368
, pp. 317-323
-
-
Kawai, H.1
Deguchi, S.2
Deguchi, K.3
-
18
-
-
0037189048
-
Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice
-
DOI 10.1016/S0006-8993(02)02649-5, PII S0006899302026495
-
Laufs U., Gertz K., Dirnagl U., Bohm M., Nickenig G., and, Endres M., (2002) Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res. 942, 23-30. (Pubitemid 34597065)
-
(2002)
Brain Research
, vol.942
, Issue.1-2
, pp. 23-30
-
-
Laufs, U.1
Gertz, K.2
Dirnagl, U.3
Bohm, M.4
Nickenig, G.5
Endres, M.6
-
19
-
-
0033800718
-
Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice
-
Laufs U., Gertz K., Huang P., Nickenig G., Bohm M., Dirnagl U., and, Endres M., (2000) Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31, 2442-2449.
-
(2000)
Stroke
, vol.31
, pp. 2442-2449
-
-
Laufs, U.1
Gertz, K.2
Huang, P.3
Nickenig, G.4
Bohm, M.5
Dirnagl, U.6
Endres, M.7
-
20
-
-
2142768247
-
Pooling of animal experimental data reveals influence of study design and publication bias
-
DOI 10.1161/01.STR.0000125719.25853.20
-
Macleod M. R., O'Collins T., Howells D. W., and, Donnan G. A., (2004) Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 35, 1203-1208. (Pubitemid 38543544)
-
(2004)
Stroke
, vol.35
, Issue.5
, pp. 1203-1208
-
-
Macleod, M.R.1
O'Collins, T.2
Howells, D.W.3
Donnan, G.A.4
-
21
-
-
0033984436
-
Current perspectives on statins
-
Maron D. J., Fazio S., and, Linton M. F., (2000) Current perspectives on statins. Circulation 101, 207-213. (Pubitemid 30044262)
-
(2000)
Circulation
, vol.101
, Issue.2
, pp. 207-213
-
-
Maron, D.J.1
Fazio, S.2
Linton, M.F.3
-
22
-
-
56649115966
-
Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia
-
Mayanagi K., Katakam P. V., Gaspar T., Domoki F., and, Busija D. W., (2008) Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia. J. Cereb. Blood Flow Metab. 28, 1927-1935.
-
(2008)
J. Cereb. Blood Flow Metab.
, vol.28
, pp. 1927-1935
-
-
Mayanagi, K.1
Katakam, P.V.2
Gaspar, T.3
Domoki, F.4
Busija, D.W.5
-
23
-
-
37249040481
-
Simvastatin in the acute phase of ischemic stroke: A safety and efficacy pilot trial
-
DOI 10.1111/j.1468-1331.2007.02015.x
-
Montaner J., Chacon P., Krupinski J., Rubio F., Millan M., Molina C. A., Hereu P., Quintana M., and, Alvarez-Sabin J., (2008) Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur. J. Neurol. 15, 82-90. (Pubitemid 350265291)
-
(2008)
European Journal of Neurology
, vol.15
, Issue.1
, pp. 82-90
-
-
Montaner, J.1
Chacon, P.2
Krupinski, J.3
Rubio, F.4
Millan, M.5
Molina, C.A.6
Hereu, P.7
Quintana, M.8
Alvarez-Sabin, J.9
-
24
-
-
0032130321
-
Pathophysiology and treatment of cerebral ischemia
-
Nagahiro S., Uno M., Sato K., Goto S., Morioka M., and, Ushio Y., (1998) Pathophysiology and treatment of cerebral ischemia. J. Med. Invest. 45, 57-70. (Pubitemid 128501267)
-
(1998)
Journal of Medical Investigation
, vol.45
, Issue.1-2
, pp. 57-70
-
-
Nagahiro, S.1
Uno, M.2
Sato, K.3
Goto, S.4
Morioka, M.5
Ushio, Y.6
-
25
-
-
0038171260
-
Uptake of rosuvastatin by isolated rat hepatocytes: Comparison with pravastatin
-
Nezasa K., Higaki K., Takeuchi M., Nakano M., and, Koike M., (2003) Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatin. Xenobiotica 33, 379-388. (Pubitemid 36688114)
-
(2003)
Xenobiotica
, vol.33
, Issue.4
, pp. 379-388
-
-
Nezasa, K.1
Higaki, K.2
Takeuchi, M.3
Nakano, M.4
Koike, M.5
-
26
-
-
78651385719
-
Statins and stroke: Prevention and beyond
-
Prinz V., and, Endres M., (2011) Statins and stroke: prevention and beyond. Curr. Opin. Neurol. 24, 75-80.
-
(2011)
Curr. Opin. Neurol.
, vol.24
, pp. 75-80
-
-
Prinz, V.1
Endres, M.2
-
27
-
-
0033398822
-
Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats
-
Pruefer D., Scalia R., and, Lefer A. M., (1999) Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler Thromb. Vasc. Biol. 19, 2894-2900. (Pubitemid 30029815)
-
(1999)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.19
, Issue.12
, pp. 2894-2900
-
-
Pruefer, D.1
Scalia, R.2
Lefer, A.M.3
-
28
-
-
0033913583
-
Inhibition of monocyte chemotactic protein-1 sysnthesis by statins
-
Romano M., Diomede L., Sironi M., et al., (2000a) Inhibition of monocyte chemotactic protein-1 synthesis by statins. Lab Invest. 80, 1095-1100. (Pubitemid 30483228)
-
(2000)
Laboratory Investigation
, vol.80
, Issue.7
, pp. 1095-1100
-
-
Romano, M.1
Diomede, L.2
Sironi, M.3
Massimiliano, L.4
Sottocorno, M.5
Polentarutti, N.6
Guglielmotti, A.7
Albani, D.8
Bruno, A.9
Fruscella, P.10
Salmona, M.11
Vecchi, A.12
Pinza, M.13
Mantovani, A.14
-
29
-
-
0033782877
-
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: Role of nitric oxide
-
Romano M., Mezzetti A., Marulli C., et al., (2000b) Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide. J. Investig. Med. 48, 183-189.
-
(2000)
J. Investig. Med.
, vol.48
, pp. 183-189
-
-
Romano, M.1
Mezzetti, A.2
Marulli, C.3
-
30
-
-
0344065373
-
Recommendations for standards regarding preclinical neuroprotective and restorative drug development
-
STAIR.
-
STAIR (1999) Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30, 2752-2758.
-
(1999)
Stroke
, vol.30
, pp. 2752-2758
-
-
-
31
-
-
78649692665
-
Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: Systematic review and meta-analysis
-
Sena E. S., Briscoe C. L., Howells D. W., Donnan G. A., Sandercock P. A., and, Macleod M. R., (2010a) Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis. J. Cereb. Blood Flow Metab. 30, 1905-1913.
-
(2010)
J. Cereb. Blood Flow Metab.
, vol.30
, pp. 1905-1913
-
-
Sena, E.S.1
Briscoe, C.L.2
Howells, D.W.3
Donnan, G.A.4
Sandercock, P.A.5
MacLeod, M.R.6
-
32
-
-
77950572352
-
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy
-
Sena E. S., van der Worp H. B., Bath P. M., Howells D. W., and, Macleod M. R., (2010b) Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol. 8, e1000344.
-
(2010)
PLoS Biol.
, vol.8
-
-
Sena, E.S.1
Van Der Worp, H.B.2
Bath, P.M.3
Howells, D.W.4
MacLeod, M.R.5
-
33
-
-
33646136668
-
Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment
-
Sironi L., Banfi C., Brioschi M., et al., (2006) Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment. Neurobiol Dis. 22, 445-451.
-
(2006)
Neurobiol Dis.
, vol.22
, pp. 445-451
-
-
Sironi, L.1
Banfi, C.2
Brioschi, M.3
-
34
-
-
80052138557
-
Statins for acute ischemic stroke
-
Squizzato A., Romualdi E., Dentali F., and, Ageno W., (2011) Statins for acute ischemic stroke. Cochrane Database Syst. Rev. C00755, 1.
-
(2011)
Cochrane Database Syst. Rev.
, vol.755 C
, pp. 1
-
-
Squizzato, A.1
Romualdi, E.2
Dentali, F.3
Ageno, W.4
-
35
-
-
0035859525
-
Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis
-
Sterne J. A., Egger M., and, Smith G. D., (2001) Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ. 323, 101-105. (Pubitemid 32681979)
-
(2001)
British Medical Journal
, vol.323
, Issue.7304
, pp. 101-105
-
-
Sterne, J.A.C.1
Egger, M.2
Smith, G.D.3
-
36
-
-
33746191327
-
Pravastatin reduces microvascular basal lamina damage following focal cerebral ischemia and reperfusion
-
DOI 10.1111/j.1460-9568.2006.04920.x
-
Trinkl A., Vosko M. R., Wunderlich N., Dichgans M., and, Hamann G. F., (2006) Pravastatin reduces microvascular basal lamina damage following focal cerebral ischemia and reperfusion. Eur. J. Neurosci. 24, 520-526. (Pubitemid 44100343)
-
(2006)
European Journal of Neuroscience
, vol.24
, Issue.2
, pp. 520-526
-
-
Trinkl, A.1
Vosko, M.R.2
Wunderlich, N.3
Dichgans, M.4
Hamann, G.F.5
-
37
-
-
0344440942
-
Serum homocysteine and the severity of coronary artery disease
-
DOI 10.1016/j.thromres.2003.08.015
-
Wald D. S., Law M., and, Morris J., (2003) Serum homocysteine and the severity of coronary artery disease. Thromb Res. 111, 55-57. (Pubitemid 37485927)
-
(2003)
Thrombosis Research
, vol.111
, Issue.1-2
, pp. 55-57
-
-
Wald, D.S.1
Law, M.2
Morris, J.3
-
38
-
-
0026512675
-
Phenobarbital induction of cytochrome P-450 gene expression
-
Waxman D. J., and, Azaroff L., (1992) Phenobarbital induction of cytochrome P-450 gene expression. Biochem. J. 281, 577-592.
-
(1992)
Biochem. J.
, vol.281
, pp. 577-592
-
-
Waxman, D.J.1
Azaroff, L.2
-
39
-
-
77953971007
-
Statins and neuroprotection: A prescription to move the field forward
-
Wood W. G., Eckert G. P., Igbavboa U., and, Muller W. E., (2010) Statins and neuroprotection: a prescription to move the field forward. Ann. N. Y. Acad Sci. 1199, 69-76.
-
(2010)
Ann. N. Y. Acad Sci.
, vol.1199
, pp. 69-76
-
-
Wood, W.G.1
Eckert, G.P.2
Igbavboa, U.3
Muller, W.E.4
-
40
-
-
0034006811
-
Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment
-
Yamada M., Huang Z., Dalkara T., Endres M., Laufs U., Waeber C., Huang P. L., Liao J. K., and, Moskowitz M. A., (2000) Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. J. Cereb. Blood Flow Metab. 20, 709-717. (Pubitemid 30217509)
-
(2000)
Journal of Cerebral Blood Flow and Metabolism
, vol.20
, Issue.4
, pp. 709-717
-
-
Yamada, M.1
Huang, Z.2
Dalkara, T.3
Endres, M.4
Laufs, U.5
Waeber, C.6
Huang, P.L.7
Liao, J.K.8
Moskowitz, M.A.9
|